Ruijuan Zhou acquired 28.00 million shares of TOUYUN BIOTECH via an off-exchange equity derivative transaction on September 24, 2026.
Prior to the acquisition, Ruijuan Zhou's long position in TOUYUN BIOTECH was 0 shares, representing 0.00%; following the acquisition, the holding changed to 28.00 million shares, with the long position ratio rising to 0.96%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.